Lee Chan Henry — SEC Form 4 filings
SEC reporting owner CIK 1980648. 29 Form 4 filings on record with FilingPulse; latest filed 2026-08-13.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-06-07 to 2026-08-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 25 filings — 51,535 shares, $16,222,073 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 91.
- Largest priced transaction: sale of 6,052 shares @ $300.19 ($1,816,724) in BeOne Medicines Ltd., filed 2025-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | SVP, General Counsel | 29 | — | 43 legs · 51,535 sh · $16,222,073 | 91 |
Form 4 filings — Lee Chan Henry
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 812 @ $194.47 · Option exercise (M): 1,058 @ $213.32 · Option exercise (M): 796 @ $159.03 · Sale (S): 2,666 @ $360 · Option exercise (M): 10,556 (derivative) @ $0 · Option exercise (M): 13,754 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-03 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,044 @ $323.69 | EDGAR |
| 2026-07-24 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 514 @ $194.47 · Option exercise (M): 665 @ $213.32 · Option exercise (M): 490 @ $159.03 · Sale (S): 1,669 @ $325 · Option exercise (M): 6,682 (derivative) @ $0 · Option exercise (M): 8,645 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-10 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 202 @ $194.47 · Option exercise (M): 266 @ $213.32 · Option exercise (M): 196 @ $159.03 · Sale (S): 664 @ $302.46 · Option exercise (M): 2,626 (derivative) @ $0 · Option exercise (M): 3,458 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 590 @ $265.98 | EDGAR |
| 2026-06-15 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 45,071 @ $0 · Sale (S): 428 @ $257.63 · Grant/award (A): 87,308 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 711 @ $270.24 · Sale (S): 160 @ $271.26 | EDGAR |
| 2026-05-15 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 101 @ $194.47 · Option exercise (M): 133 @ $213.32 · Option exercise (M): 98 @ $159.03 · Sale (S): 332 @ $310.72 · Option exercise (M): 1,313 (derivative) @ $0 · Option exercise (M): 1,729 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-10 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 101 @ $194.47 · Option exercise (M): 133 @ $213.32 · Option exercise (M): 98 @ $159.03 · Sale (S): 332 @ $311.59 · Option exercise (M): 1,313 (derivative) @ $0 · Option exercise (M): 1,729 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-13 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 110 @ $194.47 · Option exercise (M): 133 @ $213.32 · Option exercise (M): 98 @ $159.03 · Sale (S): 341 @ $300 · Option exercise (M): 1,430 (derivative) @ $0 · Option exercise (M): 1,729 (derivative) @ $0 · +1 more | EDGAR |
| 2026-03-10 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 65,390 @ $0 · Grant/award (A): 29,874 @ $0 | EDGAR |
| 2026-02-06 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 502 @ $194.47 · Option exercise (M): 662 @ $213.32 · Option exercise (M): 496 @ $159.03 · Sale (S): 664 @ $348.79 · Sale (S): 996 @ $350 · Option exercise (M): 6,526 (derivative) @ $0 · +2 more | EDGAR |
| 2026-01-09 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 202 @ $194.47 · Option exercise (M): 266 @ $213.32 · Option exercise (M): 196 @ $159.03 · Sale (S): 664 @ $331.76 · Option exercise (M): 2,626 (derivative) @ $0 · Option exercise (M): 3,458 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-12 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 101 @ $194.47 · Option exercise (M): 133 @ $213.32 · Option exercise (M): 98 @ $159.03 · Sale (S): 332 @ $318.28 · Option exercise (M): 101 @ $194.47 · Option exercise (M): 133 @ $213.32 · +8 more | EDGAR |
| 2025-11-14 | 4 | BeOne Medicines Ltd. (ONC) | Option exercise (M): 302 @ $194.47 · Option exercise (M): 398 @ $213.32 · Option exercise (M): 296 @ $159.03 · Sale (S): 664 @ $348.75 · Sale (S): 332 @ $350 · Option exercise (M): 3,926 (derivative) @ $0 · +2 more | EDGAR |
| 2025-10-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,112 @ $350 · Option exercise (M): 302 @ $194.47 · Option exercise (M): 8,961 @ $213.32 · Option exercise (M): 296 @ $159.03 · Sale (S): 664 @ $347.82 · Sale (S): 4,733 @ $350.22 · +4 more | EDGAR |
| 2025-09-12 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,112 @ $325 · Option exercise (M): 6,802 @ $194.47 · Option exercise (M): 1,796 @ $213.32 · Option exercise (M): 296 @ $159.03 · Sale (S): 4,776 @ $325.19 · Sale (S): 3,318 @ $325.73 · +5 more | EDGAR |
| 2025-08-15 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 1,112 @ $300 · Option exercise (M): 4,381 @ $194.47 · Option exercise (M): 3,849 @ $159.03 · Sale (S): 6,052 @ $300.19 · Sale (S): 3,849 @ $301.00 · Option exercise (M): 56,953 (derivative) @ $0 · +1 more | EDGAR |
| 2025-07-31 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 920 @ $304.60 | EDGAR |
| 2025-06-18 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 422 @ $266.50 | EDGAR |
| 2025-06-12 | 4 | BeOne Medicines Ltd. (ONC) | Grant/award (A): 46,878 @ $0 · Grant/award (A): 88,244 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | BeOne Medicines Ltd. (ONC) | Sale (S): 470 @ $255.78 · Sale (S): 230 @ $256.79 | EDGAR |
| 2025-03-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 40,209 @ $0 | EDGAR |
| 2025-03-03 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,205 @ $275 | EDGAR |
| 2025-02-25 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 504 @ $256.84 · Sale (S): 598 @ $258.69 · Sale (S): 100 @ $260.21 | EDGAR |
| 2024-10-02 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 1,202 @ $237.10 | EDGAR |
| 2024-08-01 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 834 @ $160.57 | EDGAR |
| 2024-06-20 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 102 @ $158.20 · Sale (S): 208 @ $159.68 · Sale (S): 129 @ $159.74 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 98,085 @ $0 · Grant/award (A): 184,795 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1980648 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →